Cancer cells were treated with Ivermectin and analyzed for 1) PARP cleavage; 2) activation of caspase-1-a characteristic feature of the pyroptotic cell death pathway; and 3) caspase-3 activity typically observed in classical apoptosis. Here, CASP3 is linked to cancer.